: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-050533 Size: 6 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-050535 Size: 6 KB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, item 8.01 Accession Number: 0001213900-23-050077 Act: 34 Size: 198 KB 网页链接
$Actelis Networks(ASNS)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001213900-23-050078 Act: 33 Size: 164 KB 网页链接
$Actelis Networks(ASNS)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001213900-23-042766 Act: 33 Size: 193 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-041172 Size: 4 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-041173 Size: 4 KB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001213900-23-038738 Act: 34 Size: 338 KB 网页链接
$Actelis Networks(ASNS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-23-038739 Act: 34 Size: 5 MB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001213900-23-037340 Act: 34 Size: 1 MB 网页链接